The project focuses on the elucidation of molecular mechanisms by which the immunologically important NF-kappaB transcription factors can be activated. Identification of the molecular components of signaling pathways will also reveal potential targets for therapeutic intervention to block activation of NF-kappaB. Inflammatory diseases are often driven by the undesirable activation of NF-kappaB. In addition, this factor figures prominently in the expression of the human immunodeficiency virus, and other clinically relevant viruses. The NF-kappaB transcription factors are normally retained in the cytoplasm by association with the inhibitory IkappaB proteins. Signals directly or indirectly related to pathogens or stress lead to phosphorylation and then proteolytic degradation of the inhibitor, thereby releasing the NF-kappaB factors to translocate to the nucleus and carry out their functions. Additional regulation is imposed via direct or indirect effects of signals on the transactivation activity of these factors once they have entered the nucleus. The present project is concerned with the delineation of several signaling paths that lead to phosphorylation and subsequent ubiquitin-dependent proteasomal degradation of the IkappaB inhibitors as well as those paths that stimulate transactivation. We have cloned CIKS, which is associated with the NEMO, the regulatory subunit of the core IkappaB kinase (IIK) complex. In addition to NEMO, the IKK core complex also contains the IkappaB kinases alpha and beta. Transfected CIKS not only activates NF-kappaB, but also the Jun Kinase. We have discovered that the IKK complex can be associated not only with CIKS, but also with two additional IKK-related kinases and with Tak1, a kinase implicated in IL-1 signal transduction. We have identified an adapter protein that may link the IKK-related kinases with the IKK core complex. These data provide evidence for a large complex containing several kinases and adapters that can surround the core IKK complex; these proteins are likely to be critical for funneling various different signals to the IKK kinases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000723-07
Application #
6506940
Study Section
(LIR)
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Niaid Extramural Activities
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Claudio, Estefania; Saret, Sun; Wang, Hongshan et al. (2009) Cell-autonomous role for NF-kappa B in immature bone marrow B cells. J Immunol 182:3406-13
Claudio, Estefania; Sønder, Søren Ulrik; Saret, Sun et al. (2009) The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. J Immunol 182:1617-30
Zhang, Xiaoren; Wang, Hongshan; Claudio, Estefania et al. (2007) A role for the IkappaB family member Bcl-3 in the control of central immunologic tolerance. Immunity 27:438-52
Claudio, E; Brown, K; Siebenlist, U (2006) NF-kappaB guides the survival and differentiation of developing lymphocytes. Cell Death Differ 13:697-701
Close, Pierre; Hawkes, Nicola; Cornez, Isabelle et al. (2006) Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia. Mol Cell 22:521-31
Wieland, Gerhard D; Nehmann, Nina; Muller, Doreen et al. (2005) Early growth response proteins EGR-4 and EGR-3 interact with immune inflammatory mediators NF-kappaB p50 and p65. J Cell Sci 118:3203-12
Siebenlist, Ulrich; Brown, Keith; Claudio, Estefania (2005) Control of lymphocyte development by nuclear factor-kappaB. Nat Rev Immunol 5:435-45
Wessells, Jennifer; Baer, Mark; Young, Howard A et al. (2004) BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. J Biol Chem 279:49995-50003
Viatour, Patrick; Dejardin, Emmanuel; Warnier, Michael et al. (2004) GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. Mol Cell 16:35-45
Xing, Lianping; Carlson, Louise; Story, Beryl et al. (2003) Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption. J Bone Miner Res 18:260-9

Showing the most recent 10 out of 22 publications